Overview

Known to be a Baltic Tiger, referred to Baltic States during their economic boom, the Republic of Lithuania, reflects good economic fortune for medicine and medical device manufacturers’ investments in the region. Drugs and devices are regulated by the State Medicines Control Agency. To access the Lithuanian market, manufacturers must obtain respective approvals from the State Medicines Control Agency. With the complex Regulatory procedures involved for successful compliance, dealing with them might pose a challenge for new entrant enroute obtaining necessary market authorizations.

Enabled with an end-to-end Regulatory capability for the Lithuanian market, Freyr assists manufacturers, right from in-country representation to registrations and licenses. Freyr’s end-to-end Regulatory affairs consulting in Lithuania span across:

  • Medical Devices
  • Pharmaceuticals
  • Cosmetics
  • Food and Dietary Supplements
  • Biologics

Freyr Offerings

  • Strategic Regulatory consulting
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • End-to-end operational support
  • Dossier preparation, review and management
  • Regulatory Submissions

Freyr Advantages

  • Expert Regulatory team with proven global RA expertise
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines